BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24088353)

  • 1. [Medicinal chemistry and pharmacology focused on cannabidiol, a major component of the fiber-type cannabis].
    Takeda S
    Yakugaku Zasshi; 2013; 133(10):1093-101. PubMed ID: 24088353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration.
    Takeda S; Okajima S; Miyoshi H; Yoshida K; Okamoto Y; Okada T; Amamoto T; Watanabe K; Omiecinski CJ; Aramaki H
    Toxicol Lett; 2012 Nov; 214(3):314-9. PubMed ID: 22963825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation, Purification, and Antimicrobial Characterization of Cannabidiolic Acid and Cannabidiol from
    Martinenghi LD; Jønsson R; Lund T; Jenssen H
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32545687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabidiol-2',6'-dimethyl ether, a cannabidiol derivative, is a highly potent and selective 15-lipoxygenase inhibitor.
    Takeda S; Usami N; Yamamoto I; Watanabe K
    Drug Metab Dispos; 2009 Aug; 37(8):1733-7. PubMed ID: 19406952
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Pellati F; Borgonetti V; Brighenti V; Biagi M; Benvenuti S; Corsi L
    Biomed Res Int; 2018; 2018():1691428. PubMed ID: 30627539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects.
    Mechoulam R; Hanus L
    Chem Phys Lipids; 2002 Dec; 121(1-2):35-43. PubMed ID: 12505688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabidiol-2',6'-dimethyl ether as an effective protector of 15-lipoxygenase-mediated low-density lipoprotein oxidation in vitro.
    Takeda S; Hirayama A; Urata S; Mano N; Fukagawa K; Imamura M; Irii A; Kitajima S; Masuyama T; Nomiyama M; Tatei S; Tomita S; Kudo T; Noguchi M; Yamaguchi Y; Okamoto Y; Amamoto T; Fukunishi Y; Watanabe K; Omiecinski CJ; Aramaki H
    Biol Pharm Bull; 2011; 34(8):1252-6. PubMed ID: 21804214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of aldose reductase activity by Cannabis sativa chemotypes extracts with high content of cannabidiol or cannabigerol.
    Smeriglio A; Giofrè SV; Galati EM; Monforte MT; Cicero N; D'Angelo V; Grassi G; Circosta C
    Fitoterapia; 2018 Jun; 127():101-108. PubMed ID: 29427593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabidiol-2',6'-dimethyl ether stimulates body weight gain in apolipoprotein E-deficient BALB/c. KOR/Stm Slc-Apoe(shl) mice.
    Takeda S; Hirota R; Teradaira S; Takeda-Imoto M; Watanabe K; Toda A; Aramaki H
    J Toxicol Sci; 2015 Dec; 40(6):739-43. PubMed ID: 26558454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat exposure of Cannabis sativa extracts affects the pharmacokinetic and metabolic profile in healthy male subjects.
    Eichler M; Spinedi L; Unfer-Grauwiler S; Bodmer M; Surber C; Luedi M; Drewe J
    Planta Med; 2012 May; 78(7):686-91. PubMed ID: 22411724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol, a Major Non-Psychotropic Cannabis Constituent Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts.
    Kogan NM; Melamed E; Wasserman E; Raphael B; Breuer A; Stok KS; Sondergaard R; Escudero AV; Baraghithy S; Attar-Namdar M; Friedlander-Barenboim S; Mathavan N; Isaksson H; Mechoulam R; Müller R; Bajayo A; Gabet Y; Bab I
    J Bone Miner Res; 2015 Oct; 30(10):1905-13. PubMed ID: 25801536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of prior foot shock stress and Δ
    Rock EM; Limebeer CL; Petrie GN; Williams LA; Mechoulam R; Parker LA
    Psychopharmacology (Berl); 2017 Jul; 234(14):2207-2217. PubMed ID: 28424834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances of cannabidiol studies in medicinal chemistry, pharmacology and therapeutics.
    Thakkar K; Ruan CH; Ruan KH
    Future Med Chem; 2021 Nov; 13(22):1935-1937. PubMed ID: 34583522
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA).
    Citti C; Pacchetti B; Vandelli MA; Forni F; Cannazza G
    J Pharm Biomed Anal; 2018 Feb; 149():532-540. PubMed ID: 29182999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Standardized
    Mabou Tagne A; Marino F; Legnaro M; Luini A; Pacchetti B; Cosentino M
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiolic acid as a selective cyclooxygenase-2 inhibitory component in cannabis.
    Takeda S; Misawa K; Yamamoto I; Watanabe K
    Drug Metab Dispos; 2008 Sep; 36(9):1917-21. PubMed ID: 18556441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary investigation of lung availability of cannabinoids by smoking marijuana or dabbing BHO and decarboxylation rate of THC- and CBD-acids.
    Hädener M; Vieten S; Weinmann W; Mahler H
    Forensic Sci Int; 2019 Feb; 295():207-212. PubMed ID: 30638755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabidiol, a major phytocannabinoid, as a potent atypical inhibitor for CYP2D6.
    Yamaori S; Okamoto Y; Yamamoto I; Watanabe K
    Drug Metab Dispos; 2011 Nov; 39(11):2049-56. PubMed ID: 21821735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HU-331 and Oxidized Cannabidiol Act as Inhibitors of Human Topoisomerase IIα and β.
    Wilson JT; Fief CA; Jackson KD; Mercer SL; Deweese JE
    Chem Res Toxicol; 2018 Feb; 31(2):137-144. PubMed ID: 29272108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Methods for the Comprehensive Analysis of Bioactive Compounds in
    Pellati F; Brighenti V; Sperlea J; Marchetti L; Bertelli D; Benvenuti S
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30322208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.